QUOIN PHARMACEUT.ADR5000

Research QUOIN PHARMACEUT.ADR5000 (2EB0) on Bullrun: market cap EUR 7.15M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker2EB0
• ExchangeF
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 7.15M
• Financial periodQ4 2025
• Net income-EUR 4.35M
• Free cash flow-EUR 5.04M

Valuation Snapshot

latest market cap is EUR 7.15M.

About QUOIN PHARMACEUT.ADR5000

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage;

Frequently asked questions

What is QUOIN PHARMACEUT.ADR5000's market cap?

QUOIN PHARMACEUT.ADR5000's market capitalization is EUR 7.15M.

What does QUOIN PHARMACEUT.ADR5000 do?

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.